Neurochemical and Psychoanalytical Approaches to Mania

Proc R Soc Med. 1977; 70(Suppl 10): 20–25.

PMCID: PMC1542820

J C Cookson and T Silverstone

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

p20-a
on p.20

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ahlenius, S; Carlsson, A; Engel, J; Svensson, T; Södersten, P. Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man. Clin Pharmacol Ther. 1973 14(4):586–591.Jul–Aug; [PubMed]
Allen, MG. Twin studies of affective illness. Arch Gen Psychiatry. 1976 Dec;33(12):1476–1478. [PubMed]
Andén, NE; Butcher, SG; Corrodi, H; Fuxe, K; Ungerstedt, U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol. 1970;11(3):303–314. [PubMed]
Beckmann, H; Heinemann, H. D-Amphetamin beim manischen Syndrom. Arzneimittelforschung. 1976;26(6):1185–1186. [PubMed]
Boakes, RJ; Bradley, PB; Candy, JM. A neuronal basis for the alerting action of (+)-amphetamine. Br J Pharmacol. 1972 Jul;45(3):391–403. [PubMed]
Brodie, HK; Murphy, DL; Goodwin, FK; Bunney, WE., Jr Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism. Clin Pharmacol Ther. 1971 12(2):218–224.Mar–Apr; [PubMed]
Bunney, WE, Jr; Gershon, ES; Murphy, DL; Goodwin, FK. Psychobiological and pharmacological studies of manic-depressive illness. J Psychiatr Res. 1972 Sep;9(3):207–226. [PubMed]
Carroll, BJ; Frazer, A; Schless, A; Mendels, J. Cholinergic reversal of manic symptoms. Lancet. 1973 Feb 24;1(7800):427–428. [PubMed]
Cookson, JC; Paton, WD. Mechanisms of neuromuscular block. A review article. Anaesthesia. 1969 Jul;24(3):395–416. [PubMed]
Cookson, J; Silverstone, T. 5-Hydroxytryptamine and dopamine pathways in mania: a pilot study of fenfluramine and pimozide. Br J Clin Pharmacol. 1976 Oct;3(5):942–943. [PubMed]
Coppen, A; Prange, AJ, Jr; Whybrow, PC; Noguera, R; Paez, JM. Methysergide in mania. A controlled trial. Lancet. 1969 Aug 16;2(7616):338–340. [PubMed]
Corsini, GU; Del Zompo, M; Manconi, S; Cianchetti, C; Mangoni, A; Gessa, GL. Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man. Adv Biochem Psychopharmacol. 1977;16:645–648. [PubMed]
Crow, TJ. Catecholamine-containing neurones and electrical self-stimulation. 2. A theoretical interpretation and some psychiatric implications. Psychol Med. 1973 Feb;3(1):66–73. [PubMed]
Court, JH; Mai, FM. A double-blind intensive crossover design trial of methysergide in mania. Med J Aust. 1970 Sep 19;2(12):526–529. [PubMed]
Domino, EF; Olds, ME. Cholinergic inhibition of self-stimulation behavior. J Pharmacol Exp Ther. 1968 Nov;164(1):202–211. [PubMed]
Frazer, A; Mendels, J. Use of L-DOPA in depression. Adv Biochem Psychopharmacol. 1977;16:671–675. [PubMed]
Gerner, RH; Post, RM; Bunney, WE., Jr A dopaminergic mechanism in mania. Am J Psychiatry. 1976 Oct;133(10):1177–1180. [PubMed]
Janowsky, DS; el-Yousef, MK; Davis, JM; Sekerke, HJ. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. 1972 Sep 23;2(7778):632–635. [PubMed]
Jouvet, M; Pujol, JF. Effects of central alterations of serotoninergic neurons upon the sleep-waking cycle. Adv Biochem Psychopharmacol. 1974;11(0):199–209. [PubMed]
Kelly, PH; Seviour, PW; Iversen, SD. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 1975 Sep 5;94(3):507–522. [PubMed]
Martin, WR; Sloan, JW; Sapira, JD; Jasinski, DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971 12(2):245–258.Mar–Apr; [PubMed]
Mendels, J; Frazer, A. Reduced central serotonergic activity in mania: implications for the relationship between depression and mania. Br J Psychiatry. 1975 Mar;126:241–248. [PubMed]
Murphy, DL; Baker, M; Goodwin, FK; Miller, H; Kotin, J; Bunney, WE., Jr L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia. 1974 Jan 9;34(1):11–20. [PubMed]
Pearce, JB. Fenfluramine in mania. Lancet. 1973 Feb 24;1(7800):427–427. [PubMed]
Pinder, RM; Brogden, RN; Swayer, R; Speight, TM; Spencer, R; Avery, GS. Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry. Drugs. 1976;12(1):1–40. [PubMed]
Post, RM; Gerner, RH; Carman, JS; Bunney WE, Letter: Effects of low doses of a dopamine-receptor stimulator in mania. Lancet. 1976 Jan 24;1(7952):203–204. [PubMed]
Post, RM; Kotin, J; Goodwin, FK; Gordon, EK. Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry. 1973 Jan;130(1):67–72. [PubMed]
Prange, AJ, Jr; Wilson, IC; Lynn, CW; Alltop, LB; Stikeleather, RA. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Arch Gen Psychiatry. 1974 Jan;30(1):56–62. [PubMed]
Rivera-Calimlim, L; Nasrallah, H; Strauss, J; Lasagna, L. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. Am J Psychiatry. 1976 Jun;133(6):646–652. [PubMed]
Sack, RL; Goodwin, FK. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid. Arch Gen Psychiatry. 1974 Nov;31(5):649–654. [PubMed]
Schildkraut, JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965 Nov;122(5):509–522. [PubMed]
Van der Velde, CD; Gordon, MW. Biochemical and pharmacological variations in manic-depressive illness. Am J Psychiatry. 1972 Sep;129(3):337–342. [PubMed]
Van Kammen, DP; Murphy, DL. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia. 1975 Nov 21;44(3):215–224. [PubMed]
Van Praag, HM; Korf, J; Dols, LC. Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity. Br J Psychiatry. 1976 Dec;129:547–555. [PubMed]
Van Woert, MH; Rosenbaum, D; Howieson, J; Bowers, MB., Jr Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. N Engl J Med. 1977 Jan 13;296(2):70–75. [PubMed]
Wise, CD; Berger, BD; Stein, L. Evidence of -noradrenergic reward receptors and serotonergic punishment receptors in the rat brain. Biol Psychiatry. 1973 Feb;6(1):3–21. [PubMed]